SUMMARY
This study was designed to investigate effects of insulin on fracture healing and expression of vascular endothelial growth factor (VEGF) in diabetic
rats. Wister rats were randomly divided into diabetic control (n=66), diabetic insulin (=66) and non-diabetic control group (n=66). Diabetes was
established by peritoneal injection of alloxan. Tibia fracture was surgically created and was allowed to heal. Radiological and biomechanical
examinations were performed on the healing tibia. Immuohistochemistry was used to assess VEGF expression in the healing fracture tissues. Cortical
reconstruction of the fracture sites in non-diabetic control and diabetic insulin groups was more rapid than in diabetic control group within 6 weeks
of the fracture. Mechanical strength of the affected tibia in the diabetic insulin and non-diabetic control group was superior to diabetic control
group. Histological examination of the fracture sites revealed a delay in chondrocyte maturation and hypertrophy in diabetic control group. VEGF
expression was widely distributed in fracture sites within the first 4 weeks in control and diabetic insulin treatment group. However VEGF expression
in the callus and periosteum in diabetic control group was much less than in diabetic insulin or non-diabetic control group. In conclusion, diabetes
delays fracture healing and adversely affects callus formation with a reduced VEGF expression at the fracture sites. Insulin therapy improves fracture
healing in diabetes rats, possibly through enhancing VEGF expression in the fractured bones.
KEY WORDS
insulin; fracture; VEGF; diabetes; rats
REFERENCES
Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res. 14: 1805-1815, 1999.
[CrossRef]
[PubMed]
Funk JR, Hale JE, Carmines D, Gooch HL, Hurwitz SR. Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthopaedic Res.
18: 126-132, 2000.
[CrossRef]
[PubMed]
Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS. The effects of local insulin delivery on diabetic fracture healing. Bone. 37: 482-490, 2005.
[CrossRef]
[PubMed]
Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg (Br). 89: 1553-1560, 2007.
[CrossRef]
[PubMed]
Huh JE, Kwon NH, Baek YH, Lee JD, Choi DY, Jingushi S, Kim KI, Park DS. Formononetin promotes early fracture healing through stimulating angiogenesis
by up-regulating VEGFR-2/Flk-1 in a rat fracture model. Int Immunopharmacol. 9: 1357-1365, 2009.
[CrossRef]
[PubMed]
Islam MS, Loots du T. Experimental rodent models of type 2 diabetes: a review. Method Finding Exper Clin Pharmacol. 31: 249-261, 2009.
[PubMed]
Kasahara T, Imai S, Kojima H, Katagi M, Kimura H, Chan L, Matsusue Y. Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture
healing in diabetic mice. Bone. 47: 617-625, 2010.
[CrossRef]
[PubMed]
Kayal RA, Alblowi J, McKenzie E, Krothapalli N, Silkman L Gerstenfeld L, Einhorn TA, Graves DT. Diabetes causes the accelerated loss of cartilage
during fracture repair which is reversed by insulin treatment. Bone. 44: 357-363, 2009.
[CrossRef]
[PubMed]
Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, Faibish D, Einhorn TA, Gerstenfeld LC, Graves DT. TNF-alpha mediates diabetes-enhanced
chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res. 25: 1604-1615, 2010.
[CrossRef]
[PubMed]
Kidd LJ, Stephens AS, Kuliwaba JS, Fazzalari NL, Wu AC, Forwood MR. Temporal pattern of gene expression and histology of stress fracture healing. Bone.
46: 369-378, 2010.
[CrossRef]
[PubMed]
Lee JH, Yang SH, Oh JM, Lee MG. Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in
patients with type I diabetes mellitus. J Pharmacy Pharmacol. 62: 1-23, 2010.
[CrossRef]
[PubMed]
Lu H, Kraut D, Gerstenfeld LC, Graves DT. Diabetes interferes with the bone formation by affecting the expression of transcription factors that
regulate osteoblast differentiation. Endocrinology. 144: 346-352, 2003.
[CrossRef]
[PubMed]
Macey LR, Kana SM, Jingushi S, Terek RM, Borretos J, Bolander ME. Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg [Am].
71: 722-733, 1989.
[PubMed]
Ogasawara A, Nakajima A, Nakajima F, Goto K, Yamazaki M. Molecular basis for affected cartilage formation and bone union in fracture healing of the
streptozotocin-induced diabetic rat. Bone. 43: 832-839, 2008.
[CrossRef]
[PubMed]
Sarahrudi K, Thomas A, Braunsteiner T, Wolf H, Vecsei V, Aharinejad S. VEGF serum concentrations in patients with long bone fractures: a comparison
between impaired and normal fracture healing. J Orthopaedic Res. 27: 1293-1297, 2009.
[CrossRef]
[PubMed]
Wukich DK, Joseph A, Ryan M, Ramirez C, Irrgang JJ. Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes. Foot Ankle
Int. 32: 120-130, 2011.
[CrossRef]
|
CITED
0
|
